Clinical Trials Directory

Trials / Completed

CompletedNCT03102931

Switching to Low Oxidant Content Cigarettes in Adult Smokers

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
30 (actual)
Sponsor
Milton S. Hershey Medical Center · Academic / Other
Sex
All
Age
21 Years – 65 Years
Healthy volunteers
Accepted

Summary

The overall objective of this clinical study is to determine if smokers who switch from their usual high reactive oxygen and nitrous oxide species (ROS/NOS) products to a low ROS/NOS product exhibit increased or decreased levels of oxidative stress/damage, respectively.

Detailed description

Researchers at Penn State Hershey are seeking healthy adult cigarette smokers between the ages of 21-65 who smoke at least 10 cigarettes a day for at least one year. The aim of this study is to evaluate the effect of reduced oxidative/ nitrogen species (ROS/RNS) cigarettes compared to high ROS/RNS cigarettes. Study participation lasts 8 weeks, with 5 study visits at the Hershey Medical Center. All eligible participants will be given Spectrum research cigarettes, provided free of charge, and will be asked to only smoke those cigarettes for the first four weeks of the study. Following that four-week period of time all participants will be given low ROS content cigarettes (American Spirit Dark Green or Pall Mall Red). Participants will be asked to smoke only these cigarettes for the final four weeks of the study, these cigarettes will also be provided to you free of charge.

Conditions

Interventions

TypeNameDescription
OTHERReduced ROS/RNS content productsParticipants will be given and asked to spoke only the cigarettes provided for them. Biosamples and surveys will be collected every 2 weeks throughout the study.
OTHERTypical to high (ROS/NOS) productsParticipants will be given and asked to spoke only the cigarettes provided for them. Biosamples and surveys will be collected every 2 weeks throughout the study.

Timeline

Start date
2017-07-11
Primary completion
2018-03-06
Completion
2018-03-06
First posted
2017-04-06
Last updated
2019-03-04

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03102931. Inclusion in this directory is not an endorsement.